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valuationof a commercial rapidurinary test (Binaxnow, Strep-
ococcus pneumoniae urinary antigen test) in children with
asopharyngeal pneumococcal carriage
. Kuurugol ∗, F. Umay Koc, G. Koturoglu, S. Aksit
Ege University, Izmir, Turkey
Background:A commercial rapid urinay pneumococcal antigen
est (Binax NOW, Porland, USA) that detects the C polysaccharide
ntigen present in all Streptococcus pneumoniae is used in diagno-
is of pneumococcal infection. Additionally to, studies report that
hildren with nasopharyngeal carriage of streptococcus pneumo-
iae had high rates of positive test results due to pneumococal
ntigen reactions.We aimed to evaluate the Binax NOW urinary
ntigen test in healthy children and determined the inﬂuence of
asopharyngeal pneumococcal carriage on the results of the anti-
en detection test.
Methods: The study was performed on healthy children and
ecevied routine clinical care at Ege University Medicine Faculty
ealth Child Policlinic, between September 2009 and March 2010.
ll of the childrenenrolledandprovidedbothnasopharyngeal swab
pecimens for culture and urine samples for the antigen detection
est.
Results: Our study included 205 children, ages between 2-60
onths, 122 (60%) males and 83 (40%) females. All of the children
ere vaccined with 7 valent-pneumococcal conjugate vaccine.
neumococcal nasopharyngeal carriage was present in 24 (10.8%)
f 223. In 16 of 24 (%66.7) nasopharyngeal carriage children, pneu-
ococ antigenwas determinedpositive in their urine sampleswith
he Binax NOW test. Also in 17 of 199 (%8.5) non nasopharyngeal
neumococ carriage children, pneumococ antigen was determined
ositive in urine samples. (p <0.001). The urine antigen detection
est was signiﬁcantly more likely to indicate a positive result for
atients who were nasopharyngeal carriers of pneumococci than
or those who were not.
Conclusion: Binax NOW test can’t be useful to diagnose pneu-
ococ infection in children because the test can be positive in thehildren who are nasopharyngeal carriers. In that situation it can
e more sensitive to use other rapid diagnosis tests.
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Incidence and risk factor study of ventriculoperitoneal shunt
infections in children: a six-year experience in a single center
J.K. Lee ∗, J.H. Lee, J.H. Choi, N.R. Yang, E.H. Choi, S.K. Kim, H.J. Lee,
K.C. Wang
Seoul National University College of Medicine, Seoul, Korea, Republic
of
Background: While introduction of ventriculoperitoneal (VP)
shunt had brought remarkable progress in managing hydro-
cephalus, associated infection has become amajor threat leading to
permanent adverse outcomes. Major aim of this study was to esti-
mate infection rate and recognize risk factors of VP shunt infections
in a single center.
Methods: In 224 pediatric patients, 333 consecutive VP shunt
placementswereperformedat SeoulNationalUniversity Children’s
Hospital, Seoul, Korea in 6 years from January 2005 to February
2011. Isolation of a bacterial pathogen from the lumbar CSF or ven-
tricular ﬂuid or blood was deﬁned as documented infection while
CSF pleocytosis with signs of infection and negative culture was
classiﬁed as probable infection.
Results: The median age at the placement was 11 months
(range 0-193 months). CNS tumor (45.6%) was the most common
cause of hydrocephalus, followed by congenital cause (25.2%) and
hemorrhage (24.6%). Thirty-ﬁve shunts (10.5%) were infected, rep-
resenting0.075 infection caseper shuntperyear. VP shunt infection
occurred a median of 1 month (range 6 days to 8 months) after
insertion. Independent risk factor for shunt infectionwas operation
before ﬁrst year of life (relative risk [RR] 2.31; 95% conﬁdence inter-
val [CI], 1.19-4.48). The most common causative microorganism
identiﬁedwas Coagulase-negative staphylococci (45.7%) followed by
Staphylococcus aureus (22.9%), Klebsiella pneumoniae (5.7%). Of 35
shunt infection cases 34 patients had shunt removal.
Conclusion: A six year study of VP shunt infection in a single
center showed incidence rate of 10.5%, representing 0.075 infec-
tion case per shunt per year.Major risk factor for VP shunt infectionstaphylococci was the most common pathogen identiﬁed.
http://dx.doi.org/10.1016/j.ijid.2012.05.780
